Anti-ZBTB7A antibody
- BOND RX™ Validated
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Polyclonal ZBTB7A antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human ZBTB7A aa 500 to C-terminus.
View Alternative Names
FBI1, LRF, ZBTB7, ZNF857A, ZBTB7A, Zinc finger and BTB domain-containing protein 7A, Factor binding IST protein 1, Factor that binds to inducer of short transcripts protein 1, HIV-1 1st-binding protein 1, Leukemia/lymphoma-related factor, POZ and Krueppel erythroid myeloid ontogenic factor, TTF-I-interacting peptide 21, Zinc finger protein 857A, FBI-1, POK erythroid myeloid ontogenic factor, Pokemon, Pokemon 1, TIP21
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZBTB7A antibody (AB70208)
IHC image of ZBTB7A staining in Human Normal Tonsil formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab70208, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZBTB7A antibody (AB70208)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon carcinoma tissue labelling ZBTB7A with ab70208 at 1/200 (1μg/ml). Detection : DAB.
- IP
Supplier Data
Immunoprecipitation - Anti-ZBTB7A antibody (AB70208)
Immunoprecipitation analysis of HeLa whole cell lysate (1 mg for IP; 1/4 of IP loaded). ab70208 was used at 3 μg/mg lysate for IP and 0.04 μg/ml for WB. Lane 1 - ab70208 IP, Lane 2 - control IgG.
All lanes:
Immunoprecipitation - Anti-ZBTB7A antibody (ab70208)
Predicted band size: 61 kDa
true
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-ZBTB7A antibody (AB70208)
All lanes:
Western blot - Anti-ZBTB7A antibody (ab70208) at 0.04 µg/mL
Lane 1:
HeLa whole cell lysate at 5 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
HeLa whole cell lysate at 50 µg
Lane 4:
293T whole cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 61 kDa
true
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZBTB7A acts as a transcriptional repressor that interacts with chromatin remodeling complexes. By binding to several DNA sites it regulates genes involved in critical cellular processes including growth and apoptosis. ZBTB7A is also part of a larger complex that includes partners like BCL6 where it contributes to the regulation of immune responses and hematopoiesis.
Pathways
ZBTB7A has significant involvement in the PI3K/AKT/mTOR signaling pathway and the Wnt/β-catenin pathway. In the PI3K/AKT/mTOR pathway it interacts with proteins like AKT1 to influence cellular growth and survival and in the Wnt/β-catenin pathway ZBTB7A works with β-catenin to regulate expression of genes key to development and cell cycle progression. These roles underline its importance in the control of cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Journal of cancer research and clinical oncology 150:380 PubMed39095579
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 55:43-54 PubMed36596853
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 18:5301-5309 PubMed31612040
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental pathology 11:642-649 PubMed31938150
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 14:4857-4862 PubMed29085492
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 14:2669-2676 PubMed28927029
2017
Applications
Unspecified application
Species
Unspecified reactive species
Asian Pacific journal of cancer prevention : APJCP 14:6315-9 PubMed24377524
2014
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 14:13511-24 PubMed23807508
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com